Description
Merit Medical Accelerates Market Growth Through High-Impact WRAPSODY-CIE Adoption & Physician Uptake; What Lies Ahead?
Merit Medical Systems reported a strong performance in the third quarter of 2025, showing substantial growth across various financial indicators. The company achieved total revenue of $384.2 million, representing a 13% increase year-over-year on a GAAP basis, and 12.5% on a constant currency basis. This robust performance was primarily driven by 7.8% constant currency organic growth, surpassing the previously forecasted 6% high range. The revenue boost was lifted by significant sales within Merit Medical Systems’ Cardiovascular segment, up 13%, and a 4% increase in the Endoscopy segment. Merit Medical Systems managed to achieve a non-GAAP operating margin of 19.7% in Q3, marking a 51 basis point rise compared to last year. Furthermore, non-GAAP EPS rose by nearly 7%, which exceeded expectations, and the company generated $53 million in free cash flow, a 38% increase year-over-year.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
